PMID: 2113000Jan 1, 1990Paper

Development of long-acting nitrate delivery systems

European Journal of Clinical Pharmacology
U E Jonsson

Abstract

In this paper pharmaceutical and biopharmaceutical aspects on the development of long-acting nitrate delivery systems are reviewed. Basic considerations and requirements are also discussed. Recent product development activities are presented, with an emphasis on nitroglycerin in transdermal form and oral isosorbide-5-mononitrate controlled-release formulations.

References

May 1, 1989·European Heart Journal·J Abrams
May 1, 1989·European Heart Journal·H M Wolff, R Bonn
May 1, 1989·European Heart Journal·J O Parker
Apr 1, 1989·Drugs·J T Flaherty
May 1, 1989·European Heart Journal·H L FungE Kowaluk
Aug 1, 1988·Clinical Pharmacokinetics·G RidoutR H Guy
Aug 1, 1987·The American Journal of Cardiology·J C CowanD G Julian
May 1, 1987·Deutsche medizinische Wochenschrift·R HeidemannN Rietbrock
Jan 1, 1986·Journal of the Royal Society of Medicine·R NigamD G Maxton
Jan 1, 1981·European Journal of Clinical Pharmacology·U AbshagenB Kaufmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.